However, a better understanding of the physiological functions of PCSK9 in extra hepatic tissues will help to estimate the potential side effects of targeting PCSK9 but also to identify potential new therapeutic implications, especially in the field of Alzheimer’s disease (AD), inflammation, heart failure, and cancer. Here, PCSK9 is linked to early-onset autosomal dominant Alzheimer disease.